##
##
##
##
|||Page|
|---|---|---|
|Chair and CEO's Report|||
|Trustees'
Report|||
|Independent
Auditor's|Report|32|
|Statement
of Financial|Activities|36|
|Balance Sheet||37|
|Statement
of Cash Flows||38|
|Notes to the financial|statements|39|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Potential Risk|Potential Risk|Potential||Impact||||Steps to mitigate risk|
|---|---|---|---|---|---|---|---|---|
|Ongoing|impact|Potential||disruption|to|service||Flexible model ofservice delivery to ensure|
|ofthe pandemic||delivery||and|continued|||best
possible
support
is
available
for|
|||reduction||in traditional||income||patients despite restrictions.|
|||streams|due to Covid|||related||Review
fundraising
activities
to
identify|
|||restrictions||||||opportunities
for
income
generation/|
|||||||||continued
evolution
of
virtual
events/|
|||||||||exploration
of grant
funding
opportunities.|
|||||||||Income
levels are closely monitored,
and|
|||||||||forecasts
reflect
prudent
assumptions|
|||||||||re ardin
sustainable
recove
lans.|
|Cost of living||Reduction||of|disposable|||As
above
plus
implementation
of|
|crisis||income leading to|||reduction||in|fundraising
plan to improve
data analysis|
|||giving||||||/marketing
to maintain
and build on strong|
|||||||||supporter
relationships.|
|||||||||Costs will be monitored
and managed
by|
|||||||||the
Finance
and
Income
Generation|
|||||||||Committee
to be in line with any significant|
|||||||||changes
in income generation.|
##
##
##
|otential|isk,|isk,|'|Potential
Im sct|Potential
Im sct|||St
stoimfti|'te.risk|
|---|---|---|---|---|---|---|---|---|---|
|Succession||||Insufficient
staff|with||suitable|Comprehensive|review
of
staffing|
|planning|and|||skills
and
experience
to||||requirements|is
underway
with
phased|
|staffing levels||||manage
the|organisation/|||recruitment|plans
to
ensure
all|
|||||deliver services||||departments|are
adequately
resourced|
|||||||||within financial|constraints|
|Cyber security||||Possible
financial,||regulatory||External
IT|consultancy
with
regular|
|||||and
reputational|||risks
if|updates
to cyber security
systems.
Staff||
|||||system
access|controls
are|||training
to ensure
awareness
of risk and||
|||||breached.||||steps
to take|in the event
of a breach.|
|||||||||Trustees
are|considering
further
steps to|
|||||||||ensure
defence
against
cyber-attacks
is||
|||||||||appropriate
and
proportionate
for
the||
|||||||||or anisation.||
|Relationship||with||This is a crucial||partnership,||Trustees and|management
continue to re-|
|the Royal|Devon|||and
it is essential||that robust||establish
and|maintain
relationships
with|
|fails to be||||arrangements
are||in|place to|key
Royal
Devon
staff
and
executives.||
|formalised||||formalise
the||contractual||Clarifications
re staffing arrangements
was||
|effectively||||relationship
including|||service|sought
from|HMRC
in July 2021
but a|
|||||delivery
/|||staffing|response
has|yet to be received.
Formal|
|||||arrangements|in||light
of|negotiations
with
the
Royal
Devon
will||
|||||HMRC
clarification|||re
VAT|proceed
once
HMRC
clarification
is||
|||||treatment||||received.||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Registered|Registered|Address:|Address:|||FORCE Cancer Charity|||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||Corner House|||||
|||||||Barrack Road|||||
|||||||Exeter|||||
|||||||EX25DW
Tek 01392402875|||||
|Registered||Charity|Number:|||1140676|||||
|Registered||Company||Number:||07529991|||||
|Patron:||||||Dr Nigel Acheson|||||
|Vice-Patrons:||||||Mr David Cantle|||||
|||||||Mr Mervyn
Hayes|||||
|Trustees:||||||Dr Anne Hong —Chair|||||
|||||||Mr Morley Sage —Vice Chair|||||
|||||||Mrs Ruth Boobier|||||
|||||||Mr Frank Cook|||||
|||||||Dr Jenny Forrest|||||
|||||||Dr Sally Kidner|||||
|||||||Mrs Louise Mayor|||||
|||||||Mr Felix Medland|||||
|||||||Mr John Renninson|||||
|||||||Mr Jeremy Roberts|||||
|||||||Mrs Sally Tapp|||||
|||||||Dr Christina
Thirlwell|||||
|Chief Executive Officer:||||||Mrs Meriel Fishwick|||||
|Finance|&|Income|Generation||Committee:|Mr Morley Sage - Chair|||||
|||||||Dr Anne Hong|||||
|||||||Mr Felix Medland|||||
|||||||Mrs Meriel Fishwick —Chief Executive Officer|||||
|||||||Mrs Julia Pitts —Chief Finance Officer|||||
|||||||Mrs Sarah
Daniels —Head|of Income|Generation|(resigned|8|
|||||||February 2022)|||||
##
##
##
|Governance|Committee:||Mr John Renninson —Chair (resigned|Mr John Renninson —Chair (resigned|Mr John Renninson —Chair (resigned|from|from|GC 4 February 2022)|GC 4 February 2022)|GC 4 February 2022)|GC 4 February 2022)|GC 4 February 2022)|GC 4 February 2022)|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||Mr Jeremy
Roberts
—Chair||(appointed|||Chair||of|GC from||4|
||||February 2022)|||||||||||
||||Dr Jenny Forrest|||||||||||
||||Dr Anne Hong|||||||||||
||||Mr Morley Sage|||||||||||
||||Mrs Meriel Fishwick —Chief Executive|||Officer||||||||
||||Mrs Julia Pitts —Chief Finance||Officer|||||||||
||||Mrs Sarah
Daniels
—Head|of Income|||Generation||||(resigned||8|
||||February 2022)|||||||||||
|Operational|Management|Team:|Mrs Meriel Fishwick —Chief Executive|||Officer||||||||
||||Mrs Julia Pitts —Chief Finance||Officer|||||||||
||||Mrs Sarah
Daniels
—Head|of Income|||Generation||||(resigned||8|
||||February 2022)|||||||||||
||||Mrs Emma Ellis —Psycho-Oncology
Services||||||Manager|||(resigned||
||||from OMT 31 March 2022)|||||||||||
||||Mrs Gait Allen —Finance Team||Manager||(appointed||||15|February||
||||2022)|||||||||||
||||Miss Naomi Cole —Community||Fundraiser|||(appointed|||15|||
||||February 2022)|||||||||||
||||Mrs Heather Taybr —Volunteer||Co-ordinator||||(appointed|||15||
||||February 2022)|||||||||||
||||Mr Oliver Watts —Fundraising||Development|||Officer||(appointed|||15|
||||February 2022)|||||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Designated|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||Note|funds|funds|funds|2022|2021|
||||E|2|f|2|2|
|Income:||||||||
|Donations
and legacies|||366,824||85,702|452,526|829,016|
|Other trading activities|||555,120|||555,120|386,050|
|Charitable
activities|||7,824|||7,824|2,593|
|Investment
income|||13,862|||13,862|21,443|
|Other income|||3,306|||3,306|3,251|
|Total income|||946,936||85,702|1,032,638|1,242,353|
|Expenditure:||||||||
|Expenditure
on raising funds|||382,359|11.386|1,100|394.845|378,401|
|Expenditure
on charitable|activities||740,210|50,234|119,838|910,282|998,957|
|Total resources expended|||1,122,569|61,620|120,938|1,305,127|1,377,358|
|Net gains/(losses)
on investments||17|19,681|||19,681|91,110|
|Net income/(expenditure)|||(155,952)|(61,620)|(35,236)|(252,808)|(43,895)|
|Transfers between
funds||22/23|(19,273)|19,273||||
|Net movement
in funds|||(175,225)|(42,347)|(35,236)|(252,808)|(43,895)|
|Funds at 31 March 2021|||1,182,811|269,687|156,329|1,608,827|1,652,722|
|Funds at 31 March 2022|||1,007,586|227,340|121,093|1,356,019|1,608,827|
##
##
##
||||||||
|---|---|---|---|---|---|---|
|Balance S|heet||Company|registered|number 07529991||
||||||2022|2021|
||||Note||8|2|
|Fixed assets|||||||
|Tangible assets|||16||179,999|264,632|
|Investments|||17|||305,979|
||||||179,999|570,611|
|Current assets|||||||
|Stocks|||||6,016|7,084|
|Debtors|||18||138,501|93,995|
|Investments|||||170,000|170,000|
|Cash at bank|and|in hand|||1,139,222|1,093,075|
|Total current|assets||||1,453,739|1,364,154|
|Liabilities|||||||
|Creditors
falling due within one year|||||(277,719)|(325,938)|
|Net current assets|||||1,176,020|1,038,216|
|Net Assets|||||1,356,019|1,608,827|
|The funds of|the|charity|||||
|Unrestricted|funds||||||
|General funds|- free reserves||||889,799|1,037,180|
|General funds|- fixed asset reserve||||117,783|145,631|
||||||1,007,582|1,182,811|
|Designated
funds|||22||227,341|269,687|
||||||1,234,923|1,452,498|
|Restricted funds|||23||121,096|156,329|
|Total charity|funds||21||1,356,019|1,608,827|
##
##
|Year Ended 31 March 2022|Year Ended 31 March 2022|Year Ended 31 March 2022|||||||
|---|---|---|---|---|---|---|---|---|
|Statement
ofCash Flows|||||||||
|||||||Note|2022|2021|
|Cash provided
by/(used
in)||operating|activities|||27|(292,414)|63,499|
|Cash flows from investing||activities|||||||
|Dividends,|interest and rents|from investment|||||13,862|21,443|
|Purchase|of property
plant and equipment||||||(961)|(8,472)|
|Proceeds|from sale of investments||||||399,171|300,163|
|Purchase|of investments||||||(82,722)|(83,927)|
|Cash used in investing
activities|||||||329,350|229,207|
|Changes|in cash and cash|equivalents|in the|reporting|period||36,936|292,706|
|Cash and|cash equivalents|at the beginning||ofthe|||1,272,286|979,580|
|reporting|period||||||||
|Cash and|cash equivalents|at the end|ofthe|reporting||28|1,309,222|1,272,286|
|period|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||Notes to the financial statements|||
|---|---|---|---|
|3.|Donations
and Legacies|||
|||2022|2021|
|||2||
||Legacies|207,151|264,151|
||In memoriam|38,138|40,984|
||Donations|89,923|209,470|
||Gift Aid|46,062|77,196|
||Grants|71,252|237,215|
|||452,526|829,016|
##
##
|rading Ac|tivities|||
|---|---|---|---|
|||2022|2021|
|Collecting|boxes|10,692|7,117|
|Fundraising|Events|350,286|243,562|
|Sales of goods and services||5,934|6,368|
|Shop sales||188,208|129,003|
|||555,120|366,050|
##
|le
activities|||
|---|---|---|
||2022|2021|
|Oncology coffee bar|2,071|213|
|Sale of support services stock|3,892|219|
|Other charitable
activities|1,861|2,161|
||7,824|2,593|
##
##
##
|6.|Investment
Income||||||
|---|---|---|---|---|---|---|
||||||2022|2021|
|||||||2|
||Interest received||||830|3,091|
||Flat rent||||6,975|6,675|
||Dividend
income||||6,057|11,677|
||||||13,862|21,443|
||All income is unrestricted.||||||
|7.|Other Income||||||
||||||2022|2021|
||||||2||
||Sundry||||3,306|3,251|
||||||3,306|3,251|
||All income is unrestricted.||||||
|8.|Expenditure
on generating||funds||||
||||||2022|2021|
|||||||5|
||Shop expenditure||||165,685|161,644|
||Fundraising|events|||220,520|206,006|
||Goods for resale||||4,428|4,233|
||Investment|management||costs|4,212|6,316|
||||||394,845|376,401|
##
##
##
##
|Notes to the financial statements|Notes to the financial statements||||
|---|---|---|---|---|
|Expenditure
on charitable
activities|||||
|||Note|2022|2021|
||||8|2|
|Patient support costs|||670,714|607,928|
|Outreach costs|||36,178|197,199|
|Innovation
grants payable||10|1,882|9,100|
|Research and expenditure|grants|11|24,250|3,958|
|Support services stock sold|||5,191|2,241|
|Extension depreciation|||36,767|36,767|
|Database depreciation|||3,474|10,027|
|Oncology coffee bar|||10,253|9,402|
|Administrative
support costs||12|99,436|103,438|
|Governance
costs||13|22,137|18,897|
||||910,282|998,957|
##
||||Unrestricted|Designated|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
||||Funds|funds|funds|2022|2021|
||||2|2|2|2|2|
|Donated|equipment||||||7,600|
|Education||||1,882||1,882|1,500|
|Other innovative||projects||||||
|||||1,882||1,882|9,100|
|11.Research|expenditure|and|grants|||
|---|---|---|---|---|---|
|||||Total|Total|
|||||2022|2021|
|||||2|2|
|Research|grant|||24,250|3,958|
|||||24,250|3,958|
##
##
##
##
||||Total|Total|
|---|---|---|---|---|
||||2022|2021|
||||2|8|
|Seconded staff costs|||84,186|87,625|
|Travel and motor||||26|
|Pffnting,|postage and stationery||1,261|1,124|
|Computer|and website costs||5,604|5,876|
|Insurance|||121|113|
|Bank charges||and interest|1,230|1,407|
|Training|and conferences||324|228|
|Depreciation|||2,378|2,596|
|Irrecoverable||VAT|1,282|1,450|
|Sundry|||3,050|2,993|
||||99,436|103,438|
##
|nce cos|ts||||
|---|---|---|---|---|
||||2022|2021|
||||2|8|
|Audit and|accountancy||11,470|10,670|
|Trustees'|indemnity|insurance|688|570|
|Seconded|staff costs||9,903|7,619|
|Legal costs|||||
|Sundries|||76|38|
||||22,137|18,897|
##
##
|to the
|financial statemen|ts|||
|---|---|---|---|---|
|sts|||2022|2021|
||||8|8|
|Salaries|and wages||720,686|748,232|
|Social security costs|||63,288|63,610|
|Pension|contributions||92,804|98,937|
||||876,778|910,979|
||||No.|No.|
|Average|number
of staff||29|32|
|Average|number
of FTE staff||20|22|
|ere two|members
staff working|at FORCE in receipt of emoluments|(gross salary|plus employe|
|contributions)
exceeding 260,000 (2021:two).|||||
||||2022|2021|
||||No.|No.|
|260,000|- 269,999||1|2|
|270,000|- 279,999||1||
##
##
##
##
##
||Freehold|Leasehold|Leasehold|Motor|Office 8 shop|Total|
|---|---|---|---|---|---|---|
||land &|property|improvements|Vehicles|equipment||
||buildings|(shop)|(centre)||||
||2|2|2||||
|Cost|||||||
|At 1 April 2021|127,238|111,892|435,388|51,116|207,066|932,700|
|Additions|||||961|961|
|Dispossls|||||(4,124)|(4,124)|
|At 31 March 2022|127,238|111,892|435,388|51,116|203,903|929,537|
|Depreciation|||||||
|At 1 April 2021|49,307|68,180|368,207|32,540|149,834|668,068|
|Charge for year|3,005|11,018|42,587|6,798|22,186|85,594|
|Dispossls|||||(4,124)|(4,124)|
|At 31 March 2022|52,312|79,198|410,794|39,338|167,896|749,538|
|Net book values|||||||
|At 31 March 2022|74,926|32,694|24,594|11,778|36,007|179,999|
|At 31 March 2021|77,931|43,712|67,181|18,576|57,232|264,632|
##
##
##
|||2022|2021|
|---|---|---|---|
|Market value at 1 April||305,979|458,039|
|Additions||82,722|83,927|
|Disposals||(399,171)|(300,163)|
|Gain/(loss)|on investments|19,681|91,110|
|Movement|in cash holdings|(9,211)|(26,934)|
|Market value at 31 March|||305,979|
|Historical|cost at 31 March||248,577|
|Listed investments:||2022|2021|
|UK Bonds|||70,647|
|UK Equities|||50,877|
|Overseas|Equities||123,322|
|Other|||51,922|
|Cash|||9,211|
|Market value at 31 March|||305,979|
##
##
||2022|2021|
|---|---|---|
||8||
|Other debtors|123,806|74,532|
|VAT refund|3,419|2,167|
|P repayments|11,276|17,296|
||138,501|93,995|
||2022|2021|
||2||
|Trade creditors|173,355|237,560|
|Other creditors|76,762|49,842|
|Accru ale|27,602|38,536|
||277,719|325,938|
##
##
##
##
|At 31 March 2022 the Charity
had annual
below:|commitments
under|non-cancellable|operating
leases as set out|operating
leases as set out|
|---|---|---|---|---|
|||2022|2021||
||Plant and|Land &|Plant &|Land &|
||machinery|buildings|machinery|buildings|
||5|2|2|2|
|Operating
leases which expire:|||||
|In less than
1 year|12,481|21,806|15,082|23,775|
|Within 2 to 5years|16,958|51,100|25,307|86,663|
|In more than 5years||131|~|156|
||29,439|73,037|40,389|110,594|
||At the year-end
there was a capital commitment|of anil (2021:anil).||||
|---|---|---|---|---|---|
|21.|Movement
on Funds|||||
|||Unrestricted|Designatednestricted|||
|||funds|funds|funds|Total|
|||8|2|8||
||At 1 April 2021|1,182,811|269,687|156,329|1,608,827|
||Surplus I (deficit) for the year after transfers|(175,225)|(42,347)|(35,236)|(252,808)|
||At 31 March 2022|1,007,586|227,340|121,093|1,356,019|
##
##
##
|22.|Designated
funds|||||||
|---|---|---|---|---|---|---|---|
||||At|Incoming|Expenditure|Transfers|Balance|
||||1.4.21||||31.3.22|
||||2||||2|
||patient Support|||||||
||FORCE@locations||2,359||(20,628)|19,273|1,014|
||Innovation||166,378||(26,132)||140,246|
||Centre Fixed Assets||3,474||(3,474)|||
||Shop Renovations|I Dilapidations|97,465||(11,386)||86,080|
||||269,687||(61,620)|19,273|227,340|
||2021 Designated|funds|At|Incoming|Expenditure|Transfers|Balance|
||Comparative||1.4.20||||31.3.21|
||||2||||6|
||Patient Support|||||||
||FORCEetlocations||3,724||(137,826)|136,471|2,369|
||Innovation||167,878||(1,500)||166,378|
||Centre Fixed Assets||13,501||(10,027)||3,474|
||Shop Renovations|IDilapidations|108,852||(11,386)||97,466|
||||293,955||(160,739)|136,471|269,687|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|2022|net assets between|funds|||||
|---|---|---|---|---|---|---|
||||Unrestricted|Designated|Restricted||
||||funds|funds|funds|Total|
||||2|2|2|6|
||Tangible
fixed assets||117,783|57,095|5,121|179,999|
||Fixed asset investments||||||
||Cash at bank and|in hand|1,023,005|170,245|115,972|1,309,222|
||Other net current|assets|(133,202)|||(133,202)|
||||1,007,586|227,340|121,093|1,356,019|
|2021|net assets between|funds|||||
||Comparative||||||
||||Unrestricted|Designated|Restricted||
||||funds|funds|funds|Total|
|||||8|2|2|
||Tangible fixed assets||145,631|73,309|45,692|264,632|
||Fixed asset investments||305,979|||305,979|
||Cash at bank and|in hand|956,060|196,378|110,637|1,263,075|
||Other net current|assets|(224,859)|||(224,859)|
||||1,182,811|269,687|156,329|1,608,827|
##
##
|Financial|instru|ments||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||2022|2021|
|||||||||||8|2|
|Financial|assets|measured|at|fair|value|through|tncome|and|expenditure||305,979|
##
##
##
##
||||||2022|2021|
|---|---|---|---|---|---|---|
||||||2|f|
||Net income/(expenditure)||for the reporting|period|(252,808)|(43,895)|
||Adjustments
for:||||||
||Depreciation
charge||||85,594|94,290|
||(Gains)/losses
on investments||||(19,681)|(91,110)|
||Dividends,
interest and rents from investment||||(13,862)|(21,443)|
||Decrease/ (Increase)|in stock|||1,068|(1,201)|
||(Increase)
in debtors||||(44,506)|(49,038)|
||(Decrease)/ Increase|in creditors|||(48,219)|175,896|
||Net cash provided
by/ (used in) operating|||activities|(292,414)|63,499|
|28.|Analysis ofcash and|cash|equivalents||||
||||||2022|2021|
||||||f||
||Cashin
hand||||1,139,222|1,093,075|
||Fixed asset investments|||||9,211|
||Current asset investments||||170,000|170,000|
||Total Cash and Cash|equivalents|||1,309,222|1,272,286|
##
##
##